Covid-19

#Coronavirus #Covid-19 #Long Covid #Omicron

Top stories: Covid-19

An update on the latest Covid-19 news by DDW Digital Content Editor Diana Spencer  With winter around the corner and cases once again on the rise, the last few weeks have seen some interesting developments related to Covid-19. We found out that Omicron infection protects against flu,… Read More

#Covid-19 #News

#Covid-19 #Immunology / Virology & Vaccines #Patent Law

DDW Editor exclusive comment on pharma’s Covid IP crisis

DDW Editor Reece Armstrong takes a look at the recent Covid-19 patent battles involving key players in the pharmaceutical sector.  There’s no doubting that when the time came for the life sciences industry to step up during the Covid-19 pandemic, it delivered. From diagnostics to PPE and eventually the launch of Covid-19… Read More

#Exclusive Content

#Covid-19 #Drug approvals #FDA #Influenza #Rare disease

This week in drug discovery (19-23 September)

News round-up for 19-23 September by DDW Editor Reece Armstrong An interesting week for clinical research and drug approvals, with rare diseases being a key focus for both the FDA and European Commission. The last week has seen data emerge on how Omicron infection could protect against influenza, how… Read More

#News

Flu virus
#Covid-19 #Flu #Immune response #Influenza #Omicron

Omicron infection likely to protect against flu

The latest Omicron variants of Covid could be protective against serious influenza infection, a leading testing expert says. The milder variants have now made Covid-19 less dangerous than the flu, though there is still the risk of developing long Covid. Dr Quinton Fivelman PhD, Chief Scientific Officer at London Medical… Read More

#Covid-19 #News #Trending News

Covid patient receiving oxygen
#Antivirals #Clinical trial #Covid-19 #Human trials

POC study proves efficacy of zapnometinib in severe Covid-19

A proof of concept (POC) study has shown the clinical benefit of zapnometinib in patients with severe Covid-19 and supports further evaluation in severe viral diseases. Atriva Therapeutics and investigators will continue to evaluate the RESPIRE data and will provide an update on the full dataset in due course. The POC… Read More

#Covid-19 #News #Trending News

#Cell and gene therapy #Covid-19 #Drug discovery #Manufacturing

The challenges and trends of cell & gene therapies 

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year.   There’s no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. This area of medicine, which… Read More

#Exclusive Content #Opinion #Trends & Analysis

Patient on ventilator
#Covid-19 #Diabetes #Long Covid

Diabetes drug could prevent severe Covid

A recent study by the University of Colorado School of Medicine shows that diabetes drug metformin is effective for preventing severe illness from Covid-19. The CU School of Medicine was part of a multi-site clinical trial into the effectiveness of metformin, ivermectin and fluvoxamine in non-hospitalised adults with Covid-19. … Read More

#Covid-19 #Editor's Choice #News #Trending News

SARS-CoV-2 virus particles
#Antibodies #Biomarkers #Clinical trials #Coronavirus #Covid-19 #Drug development #SARS-CoV-2

SARS-CoV-2 antigen levels could predict patient outcomes

The amount of SARS-CoV-2 antibodies in the blood of patients hospitalised with Covid-19 could be used to predict illness severity and other clinical outcomes.  A new study, published in the Annals of Internal Medicine, shows that higher levels of viral antigen in the blood, which… Read More

#Covid-19 #News

#BioNTech #Covid-19 #Moderna #Pfizer

Moderna sues Pfizer/BioNTech over Covid patent

Biotechnology company Moderna has filed a patent infringement lawsuit against Pfizer and BioNTech in relation to the use of its messenger RNA (mRNA) technology and Pfizer and BioNTech’s Covid-19 Comirnaty vaccine. The lawsuits, which were made in the United States and Germany, state that Pfizer and BioNTech’s Covid-19 vaccine Comirnaty… Read More

#Covid-19 #News

#Clinical trials #Covid-19 #Monkeypox

Covid researchers launch Monkeypox study  

A new study investigating a potential treatment for people who have been diagnosed with monkeypox has been launched by the same team who helped develop Covid-19 treatments.   Led by the University of Oxford, the PLATINUM study will investigate the use of Tecovirimat to see if it can… Read More

#News

#Appointment #Covid-19 #EMA #MHRA #Oncology

This week in drug discovery (15-19 August)

News round-up by DDW Editor Reece Armstrong for 15-19 August. Covid booster approvals, positive results for Malaria vaccines and new CEOs are some of the stories in this week’s news round-up.  MHRA approves Moderna’s bivalent Covid booster   The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated… Read More

#News

#Covid-19 #Moderna

MHRA approves Moderna’s bivalent Covid booster  

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an updated version of Moderna’s Covid-19 booster vaccine that targets two coronavirus variants.  Moderna’s ‘Spikevax’ booster dose targets the original coronavirus strain as well as the Omicron variant. Known as a bivalent vaccine, Spikevax was approved following… Read More

#Covid-19 #News

#Covid-19 #Drug Discovery 2022 #ELRIG #HIV #Neurology

This week in drug discovery (1-5 August)

News round-up by DDW’s Reece Armstrong for 1-5 August Research paves way for easier brain tumour diagnosis New research could pave the way to the earlier diagnosis of brain tumours through the development of a simple blood test for glioblastomas. IFC invests $30 million to improve healthcare in… Read More

#News

#Covid-19 #Investment #Latin America and the Caribbean (LAC)

IFC invests $30 million to improve healthcare in Latin America   

The International Finance Corporation (IFC) is investing $30 million in the pharmaceutical company Laboratorios Siegfried to help provide lower-income populations across the Latin America and the Caribbean (LAC) regions with better access to high-quality and affordable healthcare products.  The investment falls under IFC’s Global Health Platform (GHP) and will support… Read More

#Business & Investment #Covid-19 #News

#Covid-19 #Immunology #Immunology / Virology & Vaccines

Promising developments in pursuit to design pan-coronavirus vaccine

Researchers at the Francis Crick Institute in the UK, have shown that a specific area of the SARS-CoV-2 spike protein is a promising target for a pan-coronavirus vaccine that could offer some protection against new virus variants, common colds, and help prepare for future pandemics. Developing a vaccine that provides… Read More

#Editor's Choice #News #Trending News